Erasca | Investor Presentation Deck | 56 slides · page 15 of 56
The slide highlights the poor efficacy of current SOC and suggests binimetinib as a superior alternative.
Pitch deck · problem_statement · frame_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 6/6
callout 1/1 disclaimer 1/1 list 2/2 table 1/1 title 1/1
Components 6
primary disclaimer bullet bullet data headline
Tools 2
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.